Accessibility Menu
 
Tevogen Bio logo

Tevogen Bio

(NASDAQ) TVGN

Current Price$4.45
Market Cap$18.30M
Since IPO (2022)-99%
5 YearN/A
1 Year-93%
1 Month-68%

Tevogen Bio Financials at a Glance

Market Cap

$18.30M

Revenue (TTM)

$0.00

Net Income (TTM)

$26.28M

EPS (TTM)

$-8.88

P/E Ratio

-0.51

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.45

Volume

790

Open

$4.26

Previous Close

$4.45

Daily Range

$4.22 - $4.53

52-Week Range

$4.14 - $75.50

TVGN News

No articles available.

TVGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tevogen Bio

Industry

Biotechnology

Employees

18

CEO

Ryan Saadi, MD

Headquarters

Warren, NJ 07059, US

TVGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

14%

Return on Assets

-7%

Earnings Yield

-1.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.30M

Shares Outstanding

4.05M

Volume

790

Short Interest

0.00%

Avg. Volume

27.16K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$26.14M

EBITDA

$26.14M

Operating Cash Flow

$12.33M

Capital Expenditure

$64.44K

Free Cash Flow

$12.39M

Cash & ST Invst.

$552.37K

Total Debt

$3.10M

Tevogen Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$18.30M

N/A

Market Cap/Employee

$1.02M

N/A

Employees

18

N/A

Net Income

$4.68M

+49.4%

EBITDA

$4.61M

+50.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.55M

-59.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.12M

+11.6%

Short Term Debt

$1.98M

+5.2%

Return on Assets

-5.99%

N/A

Return on Invested Capital

9.73%

N/A

Free Cash Flow

$2.25M

+26.3%

Operating Cash Flow

$2.18M

+28.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATOSAtossa Therapeutics, Inc.
$5.26+11.68%
CLNNClene Inc.
$4.93+2.28%
TILInstil Bio, Inc.
$8.24+3.39%
CGTXCognition Therapeutics, Inc.
$0.76+27.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.55-0.11%
QQQInvesco QQQ Trust
$577.18+0.03%
INTCIntel
$44.13+0.07%

Questions About TVGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.